Zusammenfassung
Periphere neuroblastäre Tumoren sind die viertgrößte Gruppe maligner Tumoren im Kindesalter. Den weitaus größten Anteil dieser Tumoren bildet das Neuroblastom mit den Subtypen des undifferenzierten, des gering differenzierten und des differenzierenden Neuroblastoms. Außerdem gehören das Ganglioneuroblastom, ein Komposittumor aus Schwann-Zell-Stroma und Neuroblasten sowie das benigne Ganglioneurom zu den peripheren neuroblastischen Tumoren. Im Rahmen dieser Übersicht werden histopathologische Diagnosekriterien und Graduierungssysteme sowie häufige, prognostisch und therapeutisch relevante molekulare Veränderungen erläutert.
Abstract
Peripheral neuroblastic tumors represent the fourth-largest group of malignant tumors in childhood. The majority of these tumors are neuroblastomas, which can be classified into undifferentiated, poorly differentiated, and differentiating subtypes. In addition, peripheral neuroblastic tumors include ganglioneuroblastoma, a composite tumor composed of Schwannian cell stroma and neuroblasts as well as benign ganglioneuroma. In this overview, histopathological diagnostic criteria and grading systems, as well as common molecular alterations that are of prognostic and therapeutic significance, are discussed.
Literatur
Ackermann S, Cartolano M, Hero B et al (2018) A mechanistic classification of clinical phenotypes in neuroblastoma. Science 362(6419):1165–1170. https://doi.org/10.1126/science.aat6768
Alaminos M, Davalos V, Cheung N‑KV GWL, Esteller M (2004) Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma. J Natl Cancer Inst 96(16):1208–1219. https://doi.org/10.1093/jnci/djh224
Cheung N‑KV (2005) Neuroblastoma. Pediatric oncology. Springer, Berlin, Heidelberg, New York, S 87–94 (With 48 tables)
Fetahu IS, Taschner-Mandl S (2021) Neuroblastoma and the epigenome. Cancer Metastasis Rev 40(1):173–189. https://doi.org/10.1007/s10555-020-09946-y
Gesellschaft für Pädriatische Onkologie und Hämatologie (2002) Neuroblastomstudie NB97. Studienprotokoll
Janoueix-Lerosey I, Schleiermacher G, Delattre O (2010) Molecular pathogenesis of peripheral neuroblastic tumors. Oncogene 29(11):1566–1579. https://doi.org/10.1038/onc.2009.518
Jansky S, Sharma AK, Körber V, Quintero A, Toprak UH, Wecht EM, Gartlgruber M, Greco A, Chomsky E, Grünewald TGP, Henrich K‑O, Tanay A, Herrmann C, Höfer T, Westermann F (2021) Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma. Nat Genet 53(5):683–693. https://doi.org/10.1038/s41588-021-00806-1
Koelsche C, von Deimling A (2022) Methylation classifiers: Brain tumors, sarcomas, and what’s next. Genes Chromosomes Cancer 61(6):346–355. https://doi.org/10.1002/gcc.23041
Peuchmaur M, d’Amore ESG, Joshi VV, Hata J, Roald B, Dehner LP, Gerbing RB, Stram DO, Lukens JN, Matthay KK, Shimada H (2003) Revision of the International Neuroblastoma Pathology Classification: confirmation of favorable and unfavorable prognostic subsets in ganglioneuroblastoma, nodular. Cancer 98(10):2274–2281. https://doi.org/10.1002/cncr.11773
Pickles JC, Stone TJ, Jacques TS (2020) Methylation-based algorithms for diagnosis: experience from neuro-oncology. J Pathol 250(5):510–517. https://doi.org/10.1002/path.5397
RKI (2021) Krebs in Deutschland für 2017/2018
Sarnacki S, Pio L (2020) Neuroblastoma. Springer, Cham, S 57–66
Shimada H, Ikegaki N (2019) Neuroblastoma pathology and classification for precision prognosis and therapy stratification, S 1–22
Shimada H, Chatten J, Newton WA, Sachs N, Hamoudi AB, Chiba T, Marsden HB, Misugi K (1984) Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 73(2):405–416. https://doi.org/10.1093/jnci/73.2.405
Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B (1999) Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee. Cancer 86(2):349–363
Simon T (2019) S1 Leitlinie Neuroblastom. AWMF-Register-Nr.: 025/008
Theissen J, Boensch M, Spitz R, Betts D, Stegmaier S, Christiansen H, Niggli F, Schilling F, Schwab M, Simon T, Westermann F, Berthold F, Hero B (2009) Heterogeneity of the MYCN oncogene in neuroblastoma. Clin Cancer Res 15(6):2085–2090. https://doi.org/10.1158/1078-0432.CCR-08-1648
Tornóczky T, Semjén D, Shimada H, Ambros IM (2007) Pathology of peripheral neuroblastic tumors: significance of prominent nucleoli in undifferentiated/poorly differentiated neuroblastoma. Pathol Oncol Res 13(4):269–275. https://doi.org/10.1007/BF02940304
Vo KT, Matthay KK, Neuhaus J, London WB, Hero B, Ambros PF, Nakagawara A, Miniati D, Wheeler K, Pearson ADJ, Cohn SL, DuBois SG (2014) Clinical, biologic, and prognostic differences on the basis of primary tumor site in neuroblastoma: a report from the international neuroblastoma risk group project. J Clin Oncol 32(28):3169–3176. https://doi.org/10.1200/JCO.2014.56.1621
Wei M, Ye M, Dong K, Dong R (2020) Mass screening for neuroblastoma in infants. Discov Med 30(160):63–70
Westermann F, Schwab M (2002) Genetic parameters of neuroblastomas. Cancer Lett 184(2):127–147. https://doi.org/10.1016/s0304-3835(02)00199-4
WHO Classification of Tumours Editorial Board (2022) Paediatric tumours. WHO, Lyon
Zafar A, Wang W, Liu G, Wang X, Xian W, McKeon F, Foster J, Zhou J, Zhang R (2021) Molecular targeting therapies for neuroblastoma: progress and challenges. Med Res Rev 41(2):961–1021. https://doi.org/10.1002/med.21750
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M. Bernhardt und C. Vokuhl geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Schwerpunktherausgeber
Christian Vokuhl, Bonn
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Bernhardt, M., Vokuhl, C. Periphere neuroblastische Tumoren im Kindesalter. Pathologie 44, 366–372 (2023). https://doi.org/10.1007/s00292-023-01227-z
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-023-01227-z